2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Print

Presidential Session

[PS2] Presidential Session 2
【E】

Thu. Feb 17, 2022 8:30 AM - 10:00 AM Room 8 (Sakura, 1F, Kyoto International Conference Center)

Chair：Hiroji Iwata（Aichi Cancer Center Hospital），Tom Wei-Wu Chen（Department of Oncology, National Taiwan University Hospital）
Discussant：Junji Tsurutani（Advanced Cancer Translational Research Institute, Showa University），Tsutomu Iwasa（Department of Medical Oncology, Kindai University Faculty of Medicine），Naoki Niikura（Department of Breast Oncology, Tokai University），Katsutoshi Oda（Division of Integrative Genomics, The University of Tokyo）

[PS2-2] KEYNOTE-355 Asian Subset: Pembrolizumab + Chemotherapy vs Placebo + Chemotherapy for Triple-Negative Breast Cancer

○Toshimi Takano1,2, Javier Cortes3,4, David W. Cescon5, Seock-Ah Im6, Mastura Md Yusof7, Hiroji Iwata8, Norikazu Masuda9, Chiun-Sheng Huang10, Chi-Feng Chung11, Koichiro Tsugawa12, Yeon Hee Park13, Koji Matsumoto14, Kenichi Inoue15, Ava Kwong16, Sherene Loi17, Wei Fu18, Wilbur Pan18, Valia Karantza18, Hope S. Rugo19, Peter Schmid20 (1.The Cancer Institute Hospital of JFCR, Tokyo, Japan, 2.Toranomon Hospital, Tokyo, Japan, 3.International Breast Cancer Center (IBCC), Quiron Group, Madrid and Barcelona, Spain; Vall d'Hebron Institute of Oncology, Barcelona, Spain, 4.Universidad Europea de Madrid, Faculty of Biomedical and Health Sciences, Department of Medicine, Madrid, Spain, 5.Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada, 6.Seoul National University Hospital, Seoul, Republic of Korea, 7.Cancer Center at Pantai Hospital, Kuala Lumpur, Malaysia, 8.Aichi Cancer Center Hospital, Nagoya, Aichi, Japan, 9.Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan, 10.National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan, 11.Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan, 12.St Marianna University School of Medicine Hospital, Kawasaki, Japan, 13.Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea, 14.Hyogo Cancer Center, Akashi, Hyogo, Japan, 15.Saitama Cancer Center, Saitama, Japan, 16.Queen Mary and Tung Wah Hospital and The University of Hong Kong-ShenZhen Hospital, China, 17.Peter MacCallum Cancer Centre and The Sir Peter MacCallum Department of Medical Oncology, University of Melbourne, Parkville, Melbourne, VIC, Australia, 18.Merck & Co., Inc., Kenilworth, NJ, USA, 19.University of California San Francisco Comprehensive Cancer Center, San Francisco, CA, USA, 20.Barts Cancer Institute, Centre for Experimental Cancer Medicine, London, UK)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password